Annual EBIT:
$172.54M+$13.47M(+8.47%)Summary
- As of today, COLL annual earnings before interest & taxes is $172.54 million, with the most recent change of +$13.47 million (+8.47%) on December 31, 2024.
- During the last 3 years, COLL annual EBIT has risen by +$154.90 million (+878.13%).
- COLL annual EBIT is now at all-time high.
Performance
COLL EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly EBIT:
$63.62M+$27.94M(+78.30%)Summary
- As of today, COLL quarterly earnings before interest & taxes is $63.62 million, with the most recent change of +$27.94 million (+78.30%) on September 30, 2025.
- Over the past year, COLL quarterly EBIT has increased by +$8.89 million (+16.25%).
- COLL quarterly EBIT is now at all-time high.
Performance
COLL Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBIT:
$162.53M+$8.89M(+5.79%)Summary
- As of today, COLL TTM earnings before interest & taxes is $162.53 million, with the most recent change of +$8.89 million (+5.79%) on September 30, 2025.
- Over the past year, COLL TTM EBIT has dropped by -$50.83 million (-23.82%).
- COLL TTM EBIT is now -23.82% below its all-time high of $213.36 million, reached on September 30, 2024.
Performance
COLL TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
COLL EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +8.5% | +16.3% | -23.8% |
| 3Y3 Years | +878.1% | +210.8% | +3320.3% |
| 5Y5 Years | +891.0% | +224.2% | +318.2% |
COLL EBIT Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +878.1% | at high | +282.5% | -23.8% | +3320.3% |
| 5Y | 5-Year | at high | +891.0% | at high | +339.1% | -23.8% | +1530.1% |
| All-Time | All-Time | at high | +283.4% | at high | +330.7% | -23.8% | +259.9% |
COLL EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | $63.62M(+78.3%) | $162.53M(+5.8%) |
| Jun 2025 | - | $35.68M(+51.3%) | $153.63M(-7.1%) |
| Mar 2025 | - | $23.59M(-40.5%) | $165.42M(-13.5%) |
| Dec 2024 | $172.54M(+8.5%) | $39.64M(-27.6%) | $191.31M(-10.3%) |
| Sep 2024 | - | $54.73M(+15.3%) | $213.36M(+4.8%) |
| Jun 2024 | - | $47.47M(-4.0%) | $203.65M(+6.2%) |
| Mar 2024 | - | $49.47M(-19.8%) | $191.81M(+9.3%) |
| Dec 2023 | $159.07M(+362.9%) | $61.69M(+37.0%) | $175.46M(+34.6%) |
| Sep 2023 | - | $45.01M(+26.3%) | $130.40M(+23.2%) |
| Jun 2023 | - | $35.63M(+7.6%) | $105.86M(+30.2%) |
| Mar 2023 | - | $33.13M(+99.2%) | $81.33M(+113.0%) |
| Dec 2022 | $34.37M(+94.8%) | $16.63M(-18.7%) | $38.19M(+856.7%) |
| Sep 2022 | - | $20.47M(+84.2%) | -$5.05M(+55.6%) |
| Jun 2022 | - | $11.11M(+210.9%) | -$11.37M(-87.4%) |
| Mar 2022 | - | -$10.02M(+62.4%) | -$6.07M(-124.1%) |
| Dec 2021 | $17.64M(-68.8%) | -$26.61M(-288.1%) | $25.14M(-62.3%) |
| Sep 2021 | - | $14.15M(-13.8%) | $66.75M(-7.6%) |
| Jun 2021 | - | $16.41M(-22.6%) | $72.22M(-0.2%) |
| Mar 2021 | - | $21.19M(+41.3%) | $72.36M(+28.7%) |
| Dec 2020 | $56.46M(+358.9%) | $15.00M(-23.6%) | $56.23M(+44.7%) |
| Sep 2020 | - | $19.63M(+18.6%) | $38.86M(+202.2%) |
| Jun 2020 | - | $16.55M(+227.0%) | $12.86M(+247.9%) |
| Mar 2020 | - | $5.06M(+313.3%) | -$8.70M(+63.4%) |
| Dec 2019 | -$21.81M | -$2.37M(+62.8%) | -$23.75M(-128.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2019 | - | -$6.38M(-27.3%) | -$10.37M(+31.7%) |
| Jun 2019 | - | -$5.01M(+49.9%) | -$15.19M(+13.1%) |
| Mar 2019 | - | -$9.99M(-190.8%) | -$17.47M(+15.5%) |
| Dec 2018 | -$19.00M(+74.6%) | $11.00M(+198.3%) | -$20.68M(+56.4%) |
| Sep 2018 | - | -$11.19M(-53.4%) | -$47.47M(+4.5%) |
| Jun 2018 | - | -$7.29M(+44.8%) | -$49.71M(+21.9%) |
| Mar 2018 | - | -$13.21M(+16.3%) | -$63.68M(+13.5%) |
| Dec 2017 | -$74.86M(+20.4%) | -$15.78M(-17.5%) | -$73.65M(+13.8%) |
| Sep 2017 | - | -$13.43M(+36.8%) | -$85.44M(+13.2%) |
| Jun 2017 | - | -$21.26M(+8.3%) | -$98.45M(+3.2%) |
| Mar 2017 | - | -$23.18M(+16.0%) | -$101.67M(-8.1%) |
| Dec 2016 | -$94.08M(-249.7%) | -$27.58M(-4.3%) | -$94.08M(-23.9%) |
| Sep 2016 | - | -$26.44M(-8.0%) | -$75.94M(-29.2%) |
| Jun 2016 | - | -$24.47M(-57.0%) | -$58.76M(-51.2%) |
| Mar 2016 | - | -$15.59M(-65.2%) | -$38.86M(-44.4%) |
| Dec 2015 | -$26.91M(-52.3%) | -$9.44M(-1.8%) | -$26.91M(-29.4%) |
| Sep 2015 | - | -$9.27M(-102.5%) | -$20.80M(-15.3%) |
| Jun 2015 | - | -$4.58M(-26.0%) | -$18.04M(-2.8%) |
| Mar 2015 | - | -$3.63M(-9.1%) | -$17.55M(+0.6%) |
| Dec 2014 | -$17.66M(-9.6%) | -$3.33M(+48.9%) | -$17.66M(-23.2%) |
| Sep 2014 | - | -$6.50M(-59.1%) | -$14.34M(-83.1%) |
| Jun 2014 | - | -$4.09M(-9.2%) | -$7.83M(-109.2%) |
| Mar 2014 | - | -$3.74M | -$3.74M |
| Dec 2013 | -$16.12M | - | - |
FAQ
- What is Collegium Pharmaceutical, Inc. annual earnings before interest & taxes?
- What is the all-time high annual EBIT for Collegium Pharmaceutical, Inc.?
- What is Collegium Pharmaceutical, Inc. annual EBIT year-on-year change?
- What is Collegium Pharmaceutical, Inc. quarterly earnings before interest & taxes?
- What is the all-time high quarterly EBIT for Collegium Pharmaceutical, Inc.?
- What is Collegium Pharmaceutical, Inc. quarterly EBIT year-on-year change?
- What is Collegium Pharmaceutical, Inc. TTM earnings before interest & taxes?
- What is the all-time high TTM EBIT for Collegium Pharmaceutical, Inc.?
- What is Collegium Pharmaceutical, Inc. TTM EBIT year-on-year change?
What is Collegium Pharmaceutical, Inc. annual earnings before interest & taxes?
The current annual EBIT of COLL is $172.54M
What is the all-time high annual EBIT for Collegium Pharmaceutical, Inc.?
Collegium Pharmaceutical, Inc. all-time high annual earnings before interest & taxes is $172.54M
What is Collegium Pharmaceutical, Inc. annual EBIT year-on-year change?
Over the past year, COLL annual earnings before interest & taxes has changed by +$13.47M (+8.47%)
What is Collegium Pharmaceutical, Inc. quarterly earnings before interest & taxes?
The current quarterly EBIT of COLL is $63.62M
What is the all-time high quarterly EBIT for Collegium Pharmaceutical, Inc.?
Collegium Pharmaceutical, Inc. all-time high quarterly earnings before interest & taxes is $63.62M
What is Collegium Pharmaceutical, Inc. quarterly EBIT year-on-year change?
Over the past year, COLL quarterly earnings before interest & taxes has changed by +$8.89M (+16.25%)
What is Collegium Pharmaceutical, Inc. TTM earnings before interest & taxes?
The current TTM EBIT of COLL is $162.53M
What is the all-time high TTM EBIT for Collegium Pharmaceutical, Inc.?
Collegium Pharmaceutical, Inc. all-time high TTM earnings before interest & taxes is $213.36M
What is Collegium Pharmaceutical, Inc. TTM EBIT year-on-year change?
Over the past year, COLL TTM earnings before interest & taxes has changed by -$50.83M (-23.82%)